Literature DB >> 33585334

Late Erosion of Percutaneous ASD Occlusion Device.

Ronan W Cusack1, Gearoid Fitzgerald1, Mark W Kennedy1.   

Abstract

Percutaneous closure of atrial septal defects (ASDs) is an ever more common treatment modality in selected patients. Device erosion is a rare but often fatal complication of this therapy, which usually presents early in the post-procedure course. We describe the case of a patient presenting with chest pain and shock in whom early recognition and intervention prevented a negative outcome. Awareness of this potentially lethal complication is important as the population of patients undergoing percutaneous procedures for structural heart disease continues to grow. LEARNING POINTS: As the number of patients undergoing percutaneous atrial septal defect closure increases, so too will the volume presenting with late complications.Early recognition and intervention in cases of device erosion is critical to prevent death. © EFIM 2020.

Entities:  

Keywords:  Cardiac tamponade; atrial septal defect; late erosion; percutaneous ASD occlusion; structural heart disease

Year:  2020        PMID: 33585334      PMCID: PMC7875596          DOI: 10.12890/2020_002202

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  3 in total

Review 1.  Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.

Authors:  Adnan Abaci; Serkan Unlu; Yakup Alsancak; Ulker Kaya; Burak Sezenoz
Journal:  Catheter Cardiovasc Interv       Date:  2013-08-31       Impact factor: 2.692

2.  Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study.

Authors:  Doff B McElhinney; Michael D Quartermain; Damien Kenny; Ernerio Alboliras; Zahid Amin
Journal:  Circulation       Date:  2016-03-21       Impact factor: 29.690

Review 3.  Device closure of secundum atrial septal defect's and the risk of cardiac erosion.

Authors:  J D R Thomson; S A Qureshi
Journal:  Echo Res Pract       Date:  2015-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.